Matos FZ, Aranha AMF, Borges AH, Pedro FLM, Raslan SA, Hamida F, Veiga K, Porto AN. Can different stages of leprosy treatment influence the profile of oral health? Oral status in leprosy. Med Oral Patol Oral Cir Bucal. 2018 Jul 1;23 (4):e376-83.

 

 

doi:10.4317/medoral.22220

http://dx.doi.org/doi:10.4317/medoral.22220

 

References

1. Passos Vázquez CM, Mendes Netto RS, Ferreira Barbosa KB, Rodrigues MT, de Almeida RP, Duthie MS, et al. Micronutrients influencing the immune response in leprosy. Nutr Hosp. 2014;29:26-36.
PMid:24483959

 

2. Pardillo FE, Fajardo TT, Abalos RM, Scollard D, Gelber RH. Methods for the classification of leprosy for treatment purposes. Clin Infect Dis. 2007;44:1096-1099.
https://doi.org/10.1086/512809
PMid:17366457

 

3. Babu AB, Ravikiran A, Samatha Y, Nayyar AS, Arif M, Buduru K. Oral manifestations of patients with leprosy: A disease, actually infectious but not always, still a stigma in society. Egypt J Dermatol Venereol. 2015;35: 37–44.
https://doi.org/10.4103/1110-6530.162479

 

4. Amou T, Hinode D, Yoshioka M, Grenier D. Relationship between halitosis and periodontal disease - associated oral bacteria in tongue coatings. Int J Dent Hyg. 2013;12:145-51.
https://doi.org/10.1111/idh.12046
PMid:23890391

 

5. Figueiredo LC, Rosetti EP, Marcantonio E Jr, Marcantonio RA, Salvador SL. The relationship of oral malodor in patients with or without periodontal disease. J Periodontol. 2002;73:1338-42.
https://doi.org/10.1902/jop.2002.73.11.1338
PMid:12479639

 

6. Arreaza ALV, Moraes JC. Vigilância da saúde: fundamentos, interfaces e tendências. Ciência & Saúde Coletiva. 2010;15:2215-28.
https://doi.org/10.1590/S1413-81232010000400036

 

7. World Health Organization. Oral health surveys, basics methods. 4th Edition. Geneva: World Health Organization; 1997.

 

8. Orellana MF, Lagravere MO, Boychuk DGJ, Major PW, Flores-Mir C. Prevalence of Xerostomia in Population-based Samples: A Systematic Review. Journal of Public Health Dentistry. 2006;66:151-58.
https://doi.org/10.1111/j.1752-7325.2006.tb02572.x

 

9. Goulart IM, Arbex GL, Carneiro MH, Rodrigues MS, Gadia R. Adverse effects of multidrug therapy in leprosy patients: a five-year survey at a Health Center of the Federal University of Uberlândia. Rev Soc Bras Med Trop. 2002;35:453-60.
https://doi.org/10.1590/S0037-86822002000500005
PMid:12621663

 

10. Frydrych AM. Dry mouth: Xerostomia and salivary gland hypofunction. Aust Fam Physician. 2016;45:488-92.
PMid:27610431

 

11. Bretas LP, Rocha ME, Vieira MS, Rodrigues ACP. Fluxo Salivar e Capacidade Tamponante da Saliva. Pesq Bras Odontoped Clin Integr. 2008;8:289-93.
https://doi.org/10.4034/1519.0501.2008.0083.0006

 

12. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol. 1999;4:1-6.
https://doi.org/10.1902/annals.1999.4.1.1
PMid:10863370

 

13. Araújo MW, Hovey KM, Benedek JR, Grossi SG, Dorn J, Wactawski-Wende J, et al. Reproducibility of probing Depth Measurements using a constant force electronic probe: analysis of inter-and intra-eaxaminer variability. J Periodontol. 2003;74:1736-40.
https://doi.org/10.1902/jop.2003.74.12.1736

 

14. Flink H, Bergdahl M, Tegelberg A, Rosenblad A, Lagerlöf F. Prevalence of hyposalivation in relation to general health, body mass index and remaining teeth in different age groups of adults. Community Dent Oral Epidemiol. 2008;36:523–31.
https://doi.org/10.1111/j.1600-0528.2008.00432.x
PMid:18422708

 

15. Silva LFG, Lopes FF, Oliveira AEF. Estudo sobre o fluxo salivar e xerostomia em mulheres na pré e pós-menopausa. Pesq Bras Odontoped Clin Integr. 2007;7: 125-29.
https://doi.org/10.4034/1519.0501.2007.0072.0004

 

16. Donaldson AC, Riggio MP, Rolph HJ, BaggJ, Hodge PJ. Clinical examination of subjects with halitosis. Oral Dis. 2007;13:63-70.
https://doi.org/10.1111/j.1601-0825.2006.01248.x
PMid:17241432

 

17. Global leprosy update, 2014: need for early case detection. Wkly Epidemiol Rec. 2015;90:461–74.
PMid:26343055

 

18. Aquino DM, Caldas Ade J, da Silva AA, Costa JM. Perfil de hanseníase pacientes em um hiperendêmica área da Amazônia Maranhão, Brasil. Rev Soc Bras Med Trop. 2003;36:57-64.
https://doi.org/10.1590/S0037-86822003000100009
PMid:12715064

 

19. Lastoria JC, Abreu MA. Leprosy: review of the epidemiological, clinical, and etiopathogenic aspects-part 1. An Bras Dermatol. 2014;89:205–18.
https://doi.org/10.1590/abd1806-4841.20142450
PMCid:PMC4008049

 

20. Taheri JB, Mortazavi H, Moshfeghi M, Bakhshi M, Bakhtiari S, Azari-Marhabi S, et al. Oro-facial manifestations of 100 leprosy patients. Med Oral Patol Oral Cir Bucal. 2012;17:728-32.
https://doi.org/10.4317/medoral.17718
PMCid:PMC3482513

 

21. Cury MR, Paschoal VD, Nardi SM, Chierotti AP, Rodrigues Júnior AL, Chiaravalloti-Neto F. Spatial analysis of leprosy incidence and associated socioeconomic factors. Rev Saude Publica. 2012;46:110-8.
https://doi.org/10.1590/S0034-89102011005000086
PMid:22183514

 

22. Karasneh JA, Al Habashneh RA, Marzouka NA, Thornhill MH. Effect of cigarette smoking on subgingival bacteria in healthy subjects and patients with chronic periodontitis. BMC Oral Health. 2017;17:64.
https://doi.org/10.1186/s12903-017-0359-4
PMid:28327165 PMCid:PMC5361727

 

23. Fucci da Costa AP, Nery JAC, Wan-del-Rey de Oliveira ML, Cuzzi T, Ramos-e-Silva M. Oral lesions in leprosy. Indian J Dermatol Venereol Leprol 2003;69:381-5.

 

24. Souza VA, Emmerich A, Coutinho EM, Freitas MG, Silva EH, Merçon FG, et al. Dental and oral condition in leprosy patients from Serra, Brazil. Lepr Rev. 2009;80:156-63.
PMid:19743619

 

25. Almeida JR, Alencar CH, Barbosa JC, Dias AA, de Almeida ME. Autopercepção de pessoas acometidas pela hanseníase sobre sua saúde bucal e necessidade de tratamento. Cien Saude Colet. 2013;18:817-26.
https://doi.org/10.1590/S1413-81232013000300027
PMid:23546208

 

26. De Almeida ZM, Ramos AN, Raposo MT, Martins-Melo FR, Vasconcellos C. Condições de saúde bucal em casos de hanseníase em área hiperendêmica da Amazônia brasileira. Rev Inst Med Trop. 2017;59:50.

 

27. Nú-ez-Martí JM, Bagán JV, Scully C, Pe-arrocha M. Leprosy: dental and periodontal status of the anterior maxilla in 76 patients. Oral Diseases. 2004;10:19-21.
https://doi.org/10.1046/j.1354-523X.2003.00981.x

 

28. Femiano F, Lanza A, Buonaiuto, Buonaiuto C, Gombos F, Rullo R, et al. Oral manifestations of adverse drug reactions: Guidelines. J Eur Acad Dermatol Venereol. 2008;22:681–91.
https://doi.org/10.1111/j.1468-3083.2008.02637.x
PMid:18331319

 

29. Cortela DC, de Souza Junior AL, Virmond MC, Ignotti E. Inflammatory Mediators of Leprosy Reactional Episodes and Dental Infections: A Systematic Review. Mediators Inflamm. 2015;2015:548540.
https://doi.org/10.1155/2015/548540
PMid:26339136 PMCid:PMC4539113